Cargando…

Pharmacodynamics of Ceftriaxone, Ertapenem, Fosfomycin and Gentamicin in Neisseria gonorrhoeae

Objectives: To assess the in vitro effect of select antimicrobials on the growth of N. gonorrhoeae and its pharmacodynamic parameters. Methods: Time–kill assays were performed on two reference N. gonorrhoeae strains (ceftriaxone-resistant WHO X and ceftriaxone-susceptible WHO F) and one clinical N....

Descripción completa

Detalles Bibliográficos
Autores principales:	Gubenšek, Urša, de Laat, Myrthe, Foerster, Sunniva, Boyd, Anders, van Dam, Alje Pieter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944423/ https://www.ncbi.nlm.nih.gov/pubmed/35326763 http://dx.doi.org/10.3390/antibiotics11030299

Ejemplares similares

In Vitro Efficacy of Gentamicin Alone and in Combination with Ceftriaxone, Ertapenem, and Azithromycin against Multidrug-Resistant Neisseria gonorrhoeae
por: Li, Xuechun, et al.
Publicado: (2021)

Ceftriaxone-Resistant Neisseria gonorrhoeae, Japan
por: Ohnishi, Makoto, et al.
Publicado: (2011)

Time-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae
por: Foerster, Sunniva, et al.
Publicado: (2016)

In Vitro Study of the Interaction of Gentamicin with Ceftriaxone and Azithromycin against Neisseria gonorrhoeae Using Agar Dilution Method
por: Xu, Wenqi, et al.
Publicado: (2022)

Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015
por: Wind, Carolien M, et al.
Publicado: (2017)

Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017
por: Katz, Alan R.
Publicado: (2018)

Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017
por: Lefebvre, Brigitte, et al.
Publicado: (2018)

Neisseria gonorrhoeae Resistant to Ceftriaxone and Cefixime, Argentina
por: Gianecini, Ricardo, et al.
Publicado: (2016)

Neisseria gonorrhoeae Aggregation Reduces Its Ceftriaxone Susceptibility
por: Wang, Liang-Chun, et al.
Publicado: (2018)

The effectiveness of gentamicin in the treatment of Neisseria gonorrhoeae: a systematic review
por: Hathorn, Emma, et al.
Publicado: (2014)

New Clinical Strain of Neisseria gonorrhoeae with Decreased Susceptibility to Ceftriaxone, Japan
por: Deguchi, Takashi, et al.
Publicado: (2016)

Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain
por: Lahra, Monica M., et al.
Publicado: (2018)

Conjunctivitis Caused by a Strain of Neisseria gonorrhoeae That Was Less Susceptible to Ceftriaxone
por: Iwata, Akira, et al.
Publicado: (2017)

Azithromycin Resistance and Decreased Ceftriaxone Susceptibility in Neisseria gonorrhoeae, Hawaii, USA
por: Papp, John R., et al.
Publicado: (2017)

Reliability of Genetic Alterations in Predicting Ceftriaxone Resistance in Neisseria gonorrhoeae Globally
por: Lin, Eric Yu, et al.
Publicado: (2022)

Gentamicin susceptibility of Neisseria gonorrhoeae isolates from 7 provinces in China
por: Liu, Jing-Wei, et al.
Publicado: (2019)

Within-Host Genetic Variation in Neisseria gonorrhoeae over the Course of Infection
por: de Korne-Elenbaas, Jolinda, et al.
Publicado: (2022)

Genetic Resistance Determinants, In Vitro Time-Kill Curve Analysis and Pharmacodynamic Functions for the Novel Topoisomerase II Inhibitor ETX0914 (AZD0914) in Neisseria gonorrhoeae
por: Foerster, Sunniva, et al.
Publicado: (2015)

A new rapid resazurin-based microdilution assay for antimicrobial susceptibility testing of Neisseria gonorrhoeae
por: Foerster, Sunniva, et al.
Publicado: (2017)

Trends and determinants of antimicrobial susceptibility of Neisseria gonorrhoeae in the Netherlands, 2007 to 2015
por: Hofstraat, Sanne HI, et al.
Publicado: (2018)

Identification of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain FC428, China
por: Chen, Shao-Chun, et al.
Publicado: (2019)

Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial
por: Brittain, Clare, et al.
Publicado: (2016)

Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial
por: Ross, Jonathan D C, et al.
Publicado: (2019)

The Neisseria gonorrhoeae Accessory Genome and Its Association with the Core Genome and Antimicrobial Resistance
por: de Korne-Elenbaas, Jolinda, et al.
Publicado: (2022)

Molecular epidemiology of Neisseria gonorrhoeae strains circulating in Indonesia using multi-locus variable number tandem repeat analysis (MLVA) and Neisseria gonorrhoeae multi-antigen sequence typing (NG-MAST) techniques
por: Hananta, I Putu Yuda, et al.
Publicado: (2018)

Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017
por: Terkelsen, David, et al.
Publicado: (2017)

Resistance of Neisseria gonorrhoeae isolates to beta-lactam antibiotics (benzylpenicillin and ceftriaxone) in Russia, 2015–2017
por: Shaskolskiy, Boris, et al.
Publicado: (2019)

Genetic Characterization and Enhanced Surveillance of Ceftriaxone-Resistant Neisseria gonorrhoeae Strain, Alberta, Canada, 2018
por: Berenger, Byron M., et al.
Publicado: (2019)

More mutation accumulation in Neisseria gonorrhoeae (NG) with susceptibility than that in NG with decreased susceptibility to ceftriaxone
por: Liang, Jing-Yao, et al.
Publicado: (2020)

Complete Genome Sequence of Ceftriaxone-Resistant Neisseria gonorrhoeae SS3160, Isolated in Tokyo, Japan
por: Miyake, Hirofumi, et al.
Publicado: (2020)

Antimicrobial Susceptibility of Ertapenem in Neisseria gonorrhoeae Isolates Collected Within the China Gonococcal Resistance Surveillance Programme (China-GRSP) 2018
por: Xu, Wen-Qi, et al.
Publicado: (2021)

Simultaneous Detection of Neisseria gonorrhoeae and Fluoroquinolone Resistance Mutations to Enable Rapid Prescription of Oral Antibiotics
por: de Korne-Elenbaas, Jolinda, et al.
Publicado: (2020)

Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018
por: Eyre, David W, et al.
Publicado: (2018)

Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022
por: Pleininger, Sonja, et al.
Publicado: (2022)

Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016
por: Day, Michaela J., et al.
Publicado: (2018)

Systematic review and survey of Neisseria gonorrhoeae ceftriaxone and azithromycin susceptibility data in the Asia Pacific, 2011 to 2016
por: George, C. R. Robert, et al.
Publicado: (2019)

Multidrug-resistant Neisseria gonorrhoeae infection in heterosexual men with reduced susceptibility to ceftriaxone, first report in Thailand
por: Kueakulpattana, Naris, et al.
Publicado: (2021)

Molecular characterization of a ceftriaxone-resistant Neisseria gonorrhoeae strain found in Switzerland: a case report
por: Egli, Konrad, et al.
Publicado: (2021)

Tolerance to Ceftriaxone in Neisseria gonorrhoeae: Rapid Induction in WHO P Reference Strain and Detection in Clinical Isolates
por: Balduck, Margaux, et al.
Publicado: (2022)

Detection of 10 cases of ceftriaxone-resistant Neisseria gonorrhoeae in the United Kingdom, December 2021 to June 2022
por: Day, Michaela, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o4v2vodmqlu94vq3hultg714v5